Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on EquityReturn on Sales

BioScience Health Innovations (BHIC) Return on Sales (2023 - 2025)

BioScience Health Innovations (BHIC) has disclosed Return on Sales for 3 consecutive years, with 0.1% as the latest value for Q4 2025.

  • Quarterly Return on Sales fell 12.0% to 0.1% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.13% through Dec 2025, up 8.0% year-over-year, with the annual reading at 0.11% for FY2025, 7.0% up from the prior year.
  • Return on Sales for Q4 2025 was 0.1% at BioScience Health Innovations, down from 0.01% in the prior quarter.
  • The five-year high for Return on Sales was 0.35% in Q1 2025, with the low at 2.19% in Q1 2023.
  • Average Return on Sales over 3 years is 0.27%, with a median of 0.05% recorded in 2025.
  • The sharpest move saw Return on Sales surged 199bps in 2024, then fell -12bps in 2025.
  • Over 3 years, Return on Sales stood at 0.13% in 2023, then surged by 113bps to 0.02% in 2024, then plummeted by -710bps to 0.1% in 2025.
  • According to Business Quant data, Return on Sales over the past three periods came in at 0.1%, 0.01%, and 0.26% for Q4 2025, Q3 2025, and Q2 2025 respectively.